Display options
Cite
Hollands M, Logan JE. An Examination of Commercial Kits for the Determination of Glutamic Oxaloacetic Transaminase (GOT) and Glutamic Pyruvic Transaminase (GPT) in Serum. Can Med Assoc J. 1966;95(7):303-6
Hollands, M., & Logan, J. E. (1966). An Examination of Commercial Kits for the Determination of Glutamic Oxaloacetic Transaminase (GOT) and Glutamic Pyruvic Transaminase (GPT) in Serum. Canadian Medical Association journal, 95(7), 303-6.
Hollands, M, and Logan, J E. "An Examination of Commercial Kits for the Determination of Glutamic Oxaloacetic Transaminase (GOT) and Glutamic Pyruvic Transaminase (GPT) in Serum." Canadian Medical Association journal vol. 95,7 (1966): 303-6.
Hollands M, Logan JE. An Examination of Commercial Kits for the Determination of Glutamic Oxaloacetic Transaminase (GOT) and Glutamic Pyruvic Transaminase (GPT) in Serum. Can Med Assoc J. 1966 Aug 13;95(7):303-6. PMID: 20328624; PMCID: PMC1935571.
Copy Download .nbib Format: NLM
Share it on

Can Med Assoc J. 1966 Aug 13;95(7):303-6.

An Examination of Commercial Kits for the Determination of Glutamic Oxaloacetic Transaminase (GOT) and Glutamic Pyruvic Transaminase (GPT) in Serum.

Canadian Medical Association journal

M Hollands, J E Logan

PMID: 20328624 PMCID: PMC1935571

Abstract

Four kits for the detection of serum transaminase based on the spectrophotometric method and 15 kits based on the colorimetric procedure were evaluated. Two kits contained faulty reagents in both the SGOT and SGPT packages. Four of the 15 kits gave results which differed significantly from those of the reference method. The precision of the various kit procedures was adequate in each case for the determinations of SGOT and SGPT. The need to evaluate the adequacy of each kit in a routine operation before relying upon the results obtained with it is stressed.

References

  1. J Clin Invest. 1955 Jan;34(1):131-3 - PubMed
  2. Am J Clin Pathol. 1957 Jul;28(1):56-63 - PubMed
  3. Clin Chem. 1963 Apr;9:217-33 - PubMed

Publication Types